CK Life Sciences International (Holdings), Inc.'s market cap is currently HK$5.00B. The company's EPS TTM is HK$-0.002; its P/E ratio is ―; CK Life Sciences International (Holdings), Inc. is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	HK$ 5.32B	HK$ 5.28B	HK$ 5.40B	HK$ 4.94B	HK$ 4.97B
Gross Profit	HK$ 1.64B	HK$ 1.63B	HK$ 1.63B	HK$ 1.41B	HK$ 1.61B
Operating Income	HK$ 223.85M	HK$ 339.63M	HK$ 336.06M	HK$ 247.85M	HK$ 376.32M
EBITDA	HK$ 624.75M	HK$ 469.51M	HK$ 449.14M	HK$ 353.62M	HK$ 475.21M
Net Income	HK$ 17.25M	HK$ 131.96M	HK$ 162.80M	HK$ 125.23M	HK$ 181.74M
Balance Sheet
Cash & Short-Term Investments	HK$ 676.16M	HK$ 704.13M	HK$ 902.47M	HK$ 971.71M	HK$ 713.14M
Total Assets	HK$ 11.25B	HK$ 11.27B	HK$ 11.73B	HK$ 11.98B	HK$ 10.71B
Total Debt	HK$ 5.93B	HK$ 5.95B	HK$ 6.21B	HK$ 6.19B	HK$ 5.63B
Net Debt	HK$ 5.27B	HK$ 5.25B	HK$ 5.32B	HK$ 5.23B	HK$ 4.93B
Total Liabilities	HK$ 7.06B	HK$ 7.11B	HK$ 7.23B	HK$ 7.26B	HK$ 6.54B
Stockholders' Equity	HK$ 4.19B	HK$ 4.16B	HK$ 4.50B	HK$ 4.72B	HK$ 4.18B
Cash Flow
Free Cash Flow	HK$ 222.35M	HK$ 146.69M	HK$ 206.33M	HK$ 151.12M	HK$ 181.37M
Operating Cash Flow	HK$ 514.18M	HK$ 363.66M	HK$ 423.57M	HK$ 530.96M	HK$ 379.15M
Investing Cash Flow	HK$ -67.96M	HK$ -22.12M	HK$ -257.88M	HK$ -457.31M	HK$ -253.92M
Financing Cash Flow	HK$ -477.95M	HK$ -515.34M	HK$ -220.08M	HK$ 168.74M	HK$ -192.21M

Currency in HKD

CK Life Sciences International (Holdings), Inc. Earnings and Revenue History

Income Statement >

CK Life Sciences International (Holdings), Inc. Debt to Assets

Balance Sheet >

CK Life Sciences International (Holdings), Inc. Cash Flow

Cash Flow >

CK Life Sciences International (Holdings), Inc. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing